SummaryRMgm-4875
|
||||||||
*RMgm-4875| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene tagging |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 33154955 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | P. berghei ANKA 507cl1 (RMgm-7) |
| Other information parent line | P.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190). |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Zeeshan M, Tewari R |
| Name Group/Department | School of Life Sciences |
| Name Institute | University of Nottingham |
| City | Nottingham |
| Country | UK |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4875 |
| Principal name | kinesin-5-GFP |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Pbkinesin-5-GFP is located at the spindle apparatus during mitotic stages of asexual blood stage schizogony |
| Gametocyte/Gamete | Spatiotemporal dynamics of Pbkinesin-5-GFP reveal its location on the spindle apparatus during male gametogony |
| Fertilization and ookinete | During meiosis in zygote to ookinete development, Pbkinesin-5-GFP location follows spindle dynamics |
| Oocyst | Pbkinesin-5-GFP exhibits multiple nuclear foci during oocyst development |
| Sporozoite | No Pbkinesin-5-GFP signal detected in sporozoites |
| Liver stage | Pbkinesin-5-GFP exhibits multiple nuclear foci during liver stage schizogony |
| Additional remarks phenotype | Mutant/mutation Phenotype Analyses of the mutant expressing a GFP-tagged version of kinesin 5 provided evidence that: Additional information Other mutants |
Tagged: Mutant parasite with a tagged gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0807700 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0317500 | ||||||||||||||||||||||||||
| Gene product | kinesin-5 | ||||||||||||||||||||||||||
| Gene product: Alternative name | EG5 | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Name of the tag | GFP | ||||||||||||||||||||||||||
| Details of tagging | C-terminal | ||||||||||||||||||||||||||
| Additional remarks: tagging | |||||||||||||||||||||||||||
| Commercial source of tag-antibodies | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | |||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||